HYPERA (HYPE3) Main Indicators
Basic Data - HYPE3
| Company | HYPERA |
| Corporate Name | HYPERA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Fabricacão de Medicamentos Alopáticos para uso humano |
| Share | HYPE3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 28.96 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 44.39 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | GPTW, IBOVESPA, IBRA, IBRX, IBRX50, ICO2, ICON, IGC, IGCT, IGNM, ISE, ITAG, IVBX, MLCX |
| Updated 09/19/2024 | |
Relative Prices - HYPE3
| Price/Earnings | 10.84 |
| Price/SBV | 1.53 |
| Price/Net Sales | 2.29 |
| Price/CFO | 7.00 |
| Price/FCF | 8.20 |
| Price/Total Assets | 0.72 |
| Price/EBIT | 7.30 |
| Price/Working Capital | 4.55 |
| Price/NCAV | -1.97 |
| EV/EBIT | 10.22 |
| EV/EBITDA | 9.24 |
| EV/Net Sales | 3.21 |
| EV/CFO | 9.80 |
| EV/FCF | 11.48 |
| EV/Total Assets | 1.01 |
| Company Market Cap | R$ 18.34 B |
| Enterprise Value | R$ 25.69 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 28.96 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 4.48% |
| Updated 09/19/2024 | |
Income Statement - HYPE3
| Net Revenue | R$ 8.00 B |
| Gross Result | R$ 4.95 B |
| EBIT | R$ 2.51 B |
| Depreciation and Amortization | - R$ 266.34 M |
| EBITDA | R$ 2.78 B |
| Net Profit | R$ 1.69 B |
| Net Profit/Share | R$ 2.67 |
| Updated 07/25/2024 | |
| Net Revenue | R$ 2.19 B |
| Gross Result | R$ 1.33 B |
| EBIT | R$ 687.18 M |
| Depreciation and Amortization | - R$ 67.96 M |
| EBITDA | R$ 755.14 M |
| Net Profit | R$ 492.81 M |
| Profit/Share | R$ 0.78 |
| Updated 07/25/2024 | |
Price and Volume Behavior - HYPE3
| Lowest Price 52 weeks | R$ 26.88 |
| Highest Price 52 weeks | R$ 36.96 |
| Variation 2024 | -15.79% |
| Variation 1 year | -21.65% |
| Variation 2 years(total) | -26.40% |
| Variation 2 years(yearly) | -14.16% |
| Variation 3 years(total) | -4.02% |
| Variation 3 years(yearly) | -1.36% |
| Variation 4 years(total) | 10.22% |
| Variation 4 years(yearly) | 2.46% |
| Variation 5 years(total) | 5.12% |
| Variation 5 years(yearly) | 1.00% |
| Average Daily Volume (3 months) | R$ 104.36 M |
| Updated 09/19/2024 | |
Returns and Margins - HYPE3
| Return on Initial Tangible Capital | 20.67% |
| Return on Initial Invested Capital | 8.86% |
| Pre-Tax Return on Initial Tangible Capital | 31.32% |
| Pre-Tax Return on Initial Invested Capital | 13.42% |
| Return on Initial Shareholder´s Equity | 15.31% |
| Return on Initial Asset | 7.10% |
| Gross Margin | 61.86% |
| Net Margin | 21.14% |
| EBIT Margin | 31.43% |
| EBITDA Margin | 34.76% |
| Initial Asset Turnover | 0.34 |
| Financial Leverage | 2.11 |
| Liabilities/Net Worth | 1.11 |
| Net Debt/EBITDA | 2.64 |
| Updated 07/25/2024 | |
Balance Sheet - HYPE3
| Cash and Cash Equivalents | R$ 2.84 B |
| Total Assets | R$ 25.37 B |
| Short-Term Debt | R$ 1.88 B |
| Long-Term Debt | R$ 8.29 B |
| Gross Debt | R$ 10.18 B |
| Net Debt | R$ 7.34 B |
| Shareholder´s Equity | R$ 12.01 B |
| Share Book Value | R$ 18.97 |
| Common Shares | 633,420,823 |
| Preferred Shares | 0 |
| Total | 633,420,823 |
| Common Shares in Treasury | 1,163,304 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,163,304 |
| Common Shares (Except Treasury) | 632,257,519 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 632,257,519 |
| Updated 07/25/2024 | |
Cash Flow - HYPE3
| Operating Cash Flow | R$ 2.62 B |
| Cash Flow from Investments | - R$ 644.38 M |
| Financing Cash Flow | - R$ 1.28 B |
| Increase (Reduction) in Cash and Equivalents | R$ 696.63 M |
| Updated 07/25/2024 | |
| Operating Cash Flow | R$ 624.17 M |
| Cash Flow from Investments | - R$ 121.64 M |
| Financing Cash Flow | - R$ 840.85 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 338.33 M |
| Updated 07/25/2024 | |
Experimental - HYPE3
| CAPEX 3 months | - R$ 83.06 M |
| Free Cash Flow 3 months | R$ 541.11 M |
| CAPEX 12 months | - R$ 382.34 M |
| Free Cash Flow 12 months | R$ 2.24 B |
| Updated 07/25/2024 | |